CD103TCR

Nurcin Liman1, Can Li1, Megan A Luckey1

  • 1Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.

Nature communications
|July 18, 2025
PubMed
概括

集成蛋白CD103标记了在小结腺中负性选择期间的自反应性T细胞. 它的表达有助于消除这些细胞,防止自身免疫性疾病,如实验性自身免疫性脑膜炎.